Dr. Art Rastinehad Receives 12th Castle Connolly Top Doctor Recognition

Dr. Art Rastinehad, a urologist and radiologist at Lenox Hill Hospital, has been named a 2026 Castle Connolly Top Doctor for the 12th time, highlighting his contributions to precision prostate cancer care and minimally invasive treatments.

SA Metrowire Staff
Healthcare
Dr. Art Rastinehad Receives 12th Castle Connolly Top Doctor Recognition

Art Rastinehad, DO, has been selected as a 2026 Castle Connolly Top Doctor, marking his 12th year receiving this honor. Only 7 percent of licensed physicians nationwide earn this designation each year, which is based on peer nominations and rigorous evaluation by Castle Connolly's physician-led research team. Dr. Rastinehad serves as professor of urology and radiology, vice chair of urology at Northwell's Lenox Hill Hospital, and Northwell Health System director for prostate cancer.

Dr. Rastinehad's clinical and research focus includes precision prostate cancer diagnosis, MRI-targeted biopsy, focal therapy, image-guided treatment, interventional urology, and prostate artery embolization for benign prostatic hyperplasia (BPH). He emphasizes a patient-centered approach: "Every patient deserves a careful review of his PSA history, MRI findings, biopsy results, prostate size, urinary symptoms, cancer risk, and personal goals before choosing a treatment path. Precision prostate care means matching the right patient to the right diagnosis and the right treatment — not taking a one-size-fits-all approach."

His research team contributed to early validation of MR/US fusion biopsy for prostate cancer detection in the United States and continues to advance focal therapy planning and minimally invasive treatments. Dr. Rastinehad was the first dual fellowship-trained urologic oncologist and interventional radiologist, completing advanced training through the National Institutes of Health, the National Cancer Institute, and Northwell's North Shore University Hospital. This unique background allows him to integrate cancer surgery, advanced imaging, and image-guided therapy.

Key career achievements include being part of the first team to publish on prostate artery embolization in 2006, early validation of MR/US fusion biopsy, and serving as principal investigator in developing UroNav/Philips MR/US fusion technology for biopsy and focal therapy planning. He is also a founding executive board member of the Focal Therapy Society and has over 20 years of experience in interventional urology.

Dr. Rastinehad practices at the urology department at Lenox Hill Hospital, offering advanced prostate care for men with elevated PSA, abnormal MRI, localized prostate cancer, enlarged prostate, and complex treatment decisions. The Castle Connolly Top Doctors list is published at castleconnolly.com and in partner publications, with selections based on medical education, training, hospital appointments, and disciplinary history. Doctors cannot pay to be included.

Blockchain Registration

QR Code for Blockchain Registration